![]()
|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Papers In Press, published online ahead of print November 15, 2007
Clinical Biochemistry, Rigshospitalet, Copenhagen 2100
Corresponding Author: christina.christoffersen{at}rh.regionh.dk
To investigate the role of apoM in HDL metabolism and atherogenesis, we generated human apoM transgenic (apoM-Tg) and apoM-deficient (apoM-/-) mice. Plasma apoM was predominantly associated with 10-12 nm-sized a-migrating HDL particles. Human apoM overexpression (11-fold) increased plasma cholesterol concentration by 13-22%, whereas apoM deficiency decreased it by 17-21%. The size and charge of apoA-I-containing HDL in plasma were not changed in apoM-Tg or apoM-/- mice. However, in plasma incubated at 37ºC, lecithin:cholesterol acyltransferase (LCAT)-dependent conversion of a- to prea-migrating HDL was delayed in apoM-Tg mice. Moreover, LCAT-independent generation of preß-migrating apoA-I-containing particles in plasma was increased in apoM-Tg mice (4.2±1.1%, P=0.06) and decreased in apoM-/- mice (0.5±0.3%, P=0.03) vs. controls (1.8±0.05%). In the setting of LDL-receptor deficiency, apoM-Tg mice with ~2-fold increased plasma apoM concentrations developed smaller atherosclerotic lesions than controls. The effect of apoM on atherosclerosis may be facilitated by enzymatic modulation of plasma HDL particles, increased cholesterol efflux from foam cells, and an antioxidative effect of apoM-containing HDL.
J. Biol. Chem, 10.1074/jbc.M704576200
Submitted on June 4, 2007
Revised on October 22, 2007
Accepted on November 15, 2007
Effect of apolipoprotein M on HDL metabolism and atherosclerosis in LDL receptor knockout mice
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
J. Ahnstrom, O. Axler, M. Jauhiainen, V. Salomaa, A. S. Havulinna, C. Ehnholm, R. Frikke-Schmidt, A. Tybjaerg-Hansen, and B. Dahlback Levels of apolipoprotein M are not associated with the risk of coronary heart disease in two independent case-control studies J. Lipid Res., September 1, 2008; 49(9): 1912 - 1917. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Wolfrum, J. J. Howell, E. Ndungo, and M. Stoffel Foxa2 Activity Increases Plasma High Density Lipoprotein Levels by Regulating Apolipoprotein M J. Biol. Chem., June 13, 2008; 283(24): 16940 - 16949. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |